Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials. Miyahara S, Ramchandani R, Kim S, Evans SR, et al. Clin Infect Dis 2020;70:698-703.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Miyahara S, Ramchandani R, Kim S, Evans SR, et al. Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials. Clin Infect Dis 2020;70:698-703.
PMID: 31414121